Tounjian Advisory Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$679K Sell
2,674
-9,932
-79% -$2.31M 0.29% 59
2026
Q1
$3.08M Sell
12,606
-292
-2% -$68K 1.11% 17
2025
Q4
$2.67M Sell
12,898
-4,626
-26% -$915K 0.9% 25
2025
Q3
$3.25M Sell
17,524
-10,200
-37% -$1.75M 1.09% 21
2025
Q2
$4.6M Sell
27,724
-486
-2% -$74.7K 0.89% 27
2025
Q1
$4.68M Buy
+28,210
New +$4.41M 0.88% 28

Other funds holding JNJ

Tounjian Advisory Partners's JNJ Position: Q2 2026 in Review

Tounjian Advisory Partners reduced its Johnson & Johnson (JNJ) stake by 79% in Q2 2026, selling an estimated $2.31M and leaving 2,674 shares worth $679K. The position accounts for 0.29% of the portfolio, ranked #59.

Tounjian Advisory Partners first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.68M in Q1 2025. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Tounjian Advisory Partners held 2,674 shares of Johnson & Johnson worth $679K as of Q2 2026.
  • Tounjian Advisory Partners sold 9,932 Johnson & Johnson shares in Q2 2026, an estimated $2.31M.
  • Johnson & Johnson made up 0.29% of Tounjian Advisory Partners's portfolio in Q2 2026, its #59 holding.
  • Tounjian Advisory Partners first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • Tounjian Advisory Partners's Johnson & Johnson position peaked at $4.68M in Q1 2025.
  • 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.